Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

JAK2 Exon 12 Mutated Polycythemia Vera: The Mayo Clinic-University of Florence Experience with 33 Consecutive Cases and Comparison with JAK2 V617F Mutated Disease

Ayalew Tefferi, MD, Sravanthi Lavu, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Naseema Gangat, MBBS, Animesh Pardanani, MBBS, PhD, Curtis A. Hanson, MD, Carmela Mannarelli, MSc, PhD, Paola Guglielmelli, MD PhD, Alessandro M. Vannucchi

Blood (2017) 130 (Supplement 1): 4191.

https://doi.org/10.1182/blood.V130.Suppl_1.4191.4191

Published: 2017

Journal Articles

Outcomes of Patients with Myeloproliferative Neoplasms (MPN) after Interferon-Alpha (IFN) Therapy Discontinuation

Juliette Soret, MD, Bruno Cassinat, PharmD, PhD, Sylvie Chevret, MD PhD, Christine Dosquet, MD PhD, Stephane Giraudier, MD PhD, Emmanuelle Verger, PhD, Nabih Maslah, PhD, Nathalie Parquet, MD, Christine Chomienne, MD PhD, Jean-Jacques Kiladjian, MD PhD

Blood (2016) 128 (22): 3106.

https://doi.org/10.1182/blood.V128.22.3106.3106

Published: 2016

Journal Articles

JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis

Jean Grisouard, Sai Li, Lucia Kubovcakova, Tata Nageswara Rao, Sara C. Meyer, Pontus Lundberg, Hui Hao-Shen, Vincent Romanet, Masato Murakami, Thomas Radimerski, Stephan Dirnhofer, Radek C. Skoda

Blood (2016) 128 (6): 839–851.

https://doi.org/10.1182/blood-2015-12-689216

Published: 2016

Includes: Supplemental data

Journal Articles

Comprehensive Analysis of JAK2 Mutations: A Single Center Experience

Nahlah AlGhasham, MD, Yasmeen Alnouri, MD, Halah Abalkhail, PhD, Salem Khalil, MD

Blood (2014) 124 (21): 5568.

https://doi.org/10.1182/blood.V124.21.5568.5568

Published: 2014

Journal Articles

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

Lasse Kjaer, Ph.D., Eric Lippert, Francois Girodon, MD, PhD, Susanne Schnittger, PhD, Serge Carillo, Caroline Riley, MD, Beatriz Bellosillo, Maj K. Westman, Ole Weis Bjerrum, MD, Marzena Wojtaszewska, Thomas Kristensen, MSc, PhD, Melanie Percy, PhD, Mary Frances McMullin, MD, MRCPath, Maruska Marusic, Caroline Rosmond, Lars Palmqvist, MD, PhD, Sylvie Hermouet, MD, Ph.D., Hans Carl Hasselbalch, MD, DMSc

Blood (2013) 122 (21): 4075.

https://doi.org/10.1182/blood.V122.21.4075.4075

Published: 2013

Journal Articles

The Molecular and Cytokine Profile of Triple-Negative ( JAK2 V617F, JAK2 exon 12, MPL negative) Myelofibrosis, a Myeloproliferative Neoplasm with Distinct Clinico-Pathologic Characteristics

Ali Tabarroki, MD, Heesun J. Rogers, MD, PhD, Valeria Visconte, PhD, Edy Hasrouni, Anjali Advani, MD, Mikkael A. Sekeres, MD, MS, Hien K. Duong, MD, Matt Kalaycio, MD, Edward A. Copelan, MD, Brady L Stein, MD, Ramon V. Tiu, MD

Blood (2012) 120 (21): 3805.

https://doi.org/10.1182/blood.V120.21.3805.3805

Published: 2012

Journal Articles

High Percentage of JAK2 exon 12 Mutation in Polycythemia Vera and Essential Thrombocythemia Among Populations of Qatar

Mohamed A. Yassin, MBBS, MSc, CABM, FACP, Hanadi Rafii El-Ayoubi, MD, Nader Al-Dewik, BSc, MSc

Blood (2012) 120 (21): 5064.

https://doi.org/10.1182/blood.V120.21.5064.5064

Published: 2012

Journal Articles

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

Blood (2011) 117 (10): 2813–2816.

https://doi.org/10.1182/blood-2010-11-316810

Published: 2011

Includes: Supplemental data

Journal Articles

The JAK2 46/1 Haplotype Analysis In Essential Thrombocythaemia and Polycythaemia Rubra Vera Reveals That CC Genotype Is Associated with a Higher JAK2V617F and c-MPL W515 Allele Burden

Shameem Mahmood, Louise Mellish, Nicholas Lea, Austin G Kulasekararaj, Atiyeh Abdallah, Sivatharsny Srirangan, Ghulam J. Mufti, DM, FRCP, FRCPath

Blood (2010) 116 (21): 1977.

https://doi.org/10.1182/blood.V116.21.1977.1977

Published: 2010

Journal Articles

Various Mutations In JAK2 Exon 12 Induce Divergent Bone Marrow Alterations

Cora Hallas, PhD, Christoph Schulte, MD, Klaus Heidorn, PhD, Markus Tiemann, MD

Blood (2010) 116 (21): 4096.

https://doi.org/10.1182/blood.V116.21.4096.4096

Published: 2010

Journal Articles

A Robust and Sensitive Method for the Detection of JAK2 Exon 12 Mutations by Using Fluorescent PCR Fragment Analysis and Allele-Specific PCR

Weisu Zhang, M.D., Frank Buccini, Elizabeth Fuentes, Roberto Zoino, Carino Puello, Bindiya Kamdar, James Weisberger, M.D.

Blood (2010) 116 (21): 4098.

https://doi.org/10.1182/blood.V116.21.4098.4098

Published: 2010

Journal Articles

Novel Mutations: Dissecting Pathogenetic Contribution

William Vainchenker, MD, PhD, Francois Delhommeau, PharmD, PhD, Isabelle Plo, Jean-Luc Villeval, Olivier Bernard

Blood (2010) 116 (21): SCI-34.

https://doi.org/10.1182/blood.V116.21.SCI-34.SCI-34

Published: 2010

Journal Articles

The JAK2 46/1 haplotype predisposes to MPL -mutated myeloproliferative neoplasms

Amy V. Jones, Peter J. Campbell, Philip A. Beer, Susanne Schnittger, Alessandro M. Vannucchi, Katerina Zoi, Melanie J. Percy, Mary Frances McMullin, Linda M. Scott, William Tapper, Richard T. Silver, David Oscier, Claire N. Harrison, Harald Grallert, Aliaksei Kisialiou, Paul Strike, Andrew J. Chase, Anthony R. Green, Nicholas C. P. Cross

Blood (2010) 115 (22): 4517–4523.

https://doi.org/10.1182/blood-2009-08-236448

Published: 2010

Includes: Supplemental data

Journal Articles

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms

Franz X. Schaub, Renate Looser, Sai Li, Hui Hao-Shen, Thomas Lehmann, Andre Tichelli, Radek C. Skoda

Blood (2010) 115 (10): 2003–2007.

https://doi.org/10.1182/blood-2009-09-245381

Published: 2010

Includes: Supplemental data

Journal Articles

Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: a European Multicenter Study.

Francesco Passamonti, Susanne Schnittger, François Girodon, Jean-Jacques Kiladjian, Mary Frances McMullin, Marco Ruggeri, Eric Lippert, Alessandro Vannucchi, Carles Besses, Elisa Rumi, Chiara Elena, Torsten Haferlach, Cristiana Pascutto, Mario Cazzola

Blood (2009) 114 (22): 3904.

https://doi.org/10.1182/blood.V114.22.3904.3904

Published: 2009

Journal Articles

The Analysis of JAK2 and MPL Mutation as Well as JAK2 SNPs in MPN Patients by MassARRAY Assay.

Su-Jiang Zhang, Hongxia Qiu, Jianyong Li, MD, PhD

Blood (2009) 114 (22): 4989.

https://doi.org/10.1182/blood.V114.22.4989.4989

Published: 2009

Journal Articles

Differential Biological Properties and Signaling Effects of Different JAK2 Alleles

M. Golam Mohi, PhD, Dongqing Yan, Haiying Zou

Blood (2008) 112 (11): 3737.

https://doi.org/10.1182/blood.V112.11.3737.3737

Published: 2008

Journal Articles

Screening JAK2 Exon 12 in JAK2 V617F Negative Patients with Myeloproliferative Disorders Reveals a New Splice Site Mutation

C. Bento, A. Estevinho, I. Rapado, S. Grande, H. Matos, M. Coucelo, S. Osorio, E. Albizua, R. Molinero, M. Duarte, C. Menezes, J. Kaeda, J. Martinez-Lopes, M. L. Ribeiro, MD, PhD

Blood (2008) 112 (11): 5238.

https://doi.org/10.1182/blood.V112.11.5238.5238

Published: 2008

Journal Articles

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

Blood (2008) 111 (10): 4922–4929.

https://doi.org/10.1182/blood-2007-11-125328

Published: 2008

Journal Articles

MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction

Gaetano M. Bergamaschi, Massimo Primignani, Giovanni Barosi, Federica M. Fabris, Laura Villani, Raffaella Reati, Alessandra Dell'Era, Pier M. Mannucci

Blood (2008) 111 (8): 4418.

https://doi.org/10.1182/blood-2008-02-137687

Published: 2008

NARROW

JAK2 Exon 12 Mutated Polycythemia Vera: The Mayo Clinic-University of Florence Experience with 33 Consecutive Cases and Comparison with JAK2 V617F Mutated Disease

Outcomes of Patients with Myeloproliferative Neoplasms (MPN) after Interferon-Alpha (IFN) Therapy Discontinuation

JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis

Comprehensive Analysis of JAK2 Mutations: A Single Center Experience

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

The Molecular and Cytokine Profile of Triple-Negative ( JAK2 V617F, JAK2 exon 12, MPL negative) Myelofibrosis, a Myeloproliferative Neoplasm with Distinct Clinico-Pathologic Characteristics

High Percentage of JAK2 exon 12 Mutation in Polycythemia Vera and Essential Thrombocythemia Among Populations of Qatar

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

The JAK2 46/1 Haplotype Analysis In Essential Thrombocythaemia and Polycythaemia Rubra Vera Reveals That CC Genotype Is Associated with a Higher JAK2V617F and c-MPL W515 Allele Burden

Various Mutations In JAK2 Exon 12 Induce Divergent Bone Marrow Alterations

A Robust and Sensitive Method for the Detection of JAK2 Exon 12 Mutations by Using Fluorescent PCR Fragment Analysis and Allele-Specific PCR

Novel Mutations: Dissecting Pathogenetic Contribution

The JAK2 46/1 haplotype predisposes to MPL -mutated myeloproliferative neoplasms

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms

Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: a European Multicenter Study.

The Analysis of JAK2 and MPL Mutation as Well as JAK2 SNPs in MPN Patients by MassARRAY Assay.

Differential Biological Properties and Signaling Effects of Different JAK2 Alleles

Screening JAK2 Exon 12 in JAK2 V617F Negative Patients with Myeloproliferative Disorders Reveals a New Splice Site Mutation

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only